Novonesis (Novozymes) B

Sign up to access all our data and the evidence and analysis underlying our overall scores. Once you've created an account, we'll get in touch with further details:

Sign Up

Direct Lobbying Transparency

Overall Assessment	Comment	Score
Comprehensive	Novonesis provides a very detailed picture of its climate-policy advocacy. It names a wide range of specific measures it has worked on, including the “Sustainable Chemistry Research and Development Act 2019” in the United States, the “Recast of the Renewable Energy Directive (REDIII)” and the broader “European Green Deal” in the EU, Denmark’s “Green Tax Reform” and National Energy and Climate Plan, Brazil’s “Revision of the microbiological normative (INC 03/2006)” on bio-stimulants, India’s “National Policy on Biofuels,” and China’s climate elements of the “14th Five-Year Plan,” among others, demonstrating full transparency about which laws and regulations it seeks to influence. It also explains how it lobbies: the company describes “participation in congressional meetings, briefings and hearings” with U.S. legislators, “direct and indirect engagements with MEPs, [the] EU Commission and Denmark (policy makers, ministries and agencies),” work “with trade association CropLife Brazil,” contributions to the Danish “Climate Partnership for Life Science & Biotech,” and policy events through the EU Chamber of Commerce in China—clearly identifying both the mechanisms (meetings, hearings, position papers, trade-association campaigns) and the governmental targets in several jurisdictions. Finally, Novonesis is explicit about the outcomes it pursues: it calls for “coordinated government support for R&D” under the U.S. sustainable chemistry act, seeks to “remove barriers to commercialization by establishing a harmonized system for registration of bio-stimulants” in Brazil and the EU, urges that “the role of biofuels should not be limited” in REDIII and that advanced biofuels receive a sub-mandate, supports a “high and comprehensive carbon tax” in Denmark, and recommends subsidy portfolios and nationwide biofuel mandates under China’s five-year plan. By disclosing the specific policies, the channels and counterparts of engagement, and the concrete legislative or regulatory changes it is advocating, the company demonstrates a comprehensive level of transparency around its climate-related lobbying activities.	4

Lobbying Governance

Overall Assessment	Comment	Score
Moderate	Novozymes sets out a foundational structure for aligning its advocacy with its climate objectives by mobilizing a cross-functional team, but it does not provide clarity on formal oversight or systematic review of its lobbying activities. For instance, the company explains that “we have dedicated regional and global departments for public affairs, regulatory affairs and sustainability” which collaborate “to ensure we a) reach Novozymes internal targets to reduce impact on climate change and b) influence regulation and policy makers to introduce political and regulatory frameworks that incentivize uptake of greener technologies.” It further acknowledges engagement on both direct and indirect channels, noting “we engage mostly through policy advocacy, complemented by work with industry and trade associations.” However, the company does not disclose any specific individual, board committee or formal audit process charged with reviewing or approving climate-related lobbying, and there is no reference to a published policy framework or monitoring procedure that governs how these engagement activities are overseen or measured for alignment with its climate change strategy.	2